Patients with T1D have a higher rate of cardiorenal events relative to T2D, which may affect health outcomes long-term. However, the majority of T1D cases now occur among older adults, who are ...
Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) anticoagulant, today highlighted a key opinion leader presen ...
New study reports protective effect among people with type 2 diabetes Kidney stones and the systemic conditions associated with them have a major impact on health and the economy in the US and ...